GCP
SLDB icon

GSA Capital Partners’s Solid Biosciences SLDB Stock Holding History

GSA Capital Partners’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$213K Buy
+29,569
New +$190K 0.01% 1429
2022
Q1 		– Sell
-7,540
Closed -$198K – 1797
2021
Q4 		$198K Buy
7,540
+833
+12% +$25.5K 0.02% 1235
2021
Q3 		$240K Buy
+6,707
New +$285K 0.02% 1146
2020
Q4 		– Sell
-877
Closed -$27K – 1561
2020
Q3 		$27K Buy
877
+182
+26% +$6.97K ﹤0.01% 1209
2020
Q2 		$31K Sell
695
-639
-48% -$26.5K 0.02% 551
2020
Q1 		$48K Buy
+1,334
New +$66K 0.01% 961
2019
Q2 		– Sell
-831
Closed -$115K – 1707
2019
Q1 		$115K Buy
+831
New +$208K 0.01% 1321

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return